Skip to main content
OpenTrials

Clinical trial condition

Metastatic Pancreatic Cancer

Explore clinical trials studying Metastatic Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

131 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Pancreatic Cancer trial results

Completed

Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer

NCT02697058

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Hirosaki University School of Medicine & Hospital Hirosaki-shi, Aomori, Japan
  • Chiba Cancer Center Chiba, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • NHO Shikoku Cancer Center Matsuyama, Ehime, Japan
View all 16 locations
View Trial Details
Completed

QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

NCT01231347

Conditions
Adenocarcinoma of the Pancreas, Advanced Malignancy, Advanced Solid Tumors, +29 more
Locations
  • Research Site Fullerton, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 152 locations
View Trial Details
Completed

FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine

NCT02827201

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Clinique Privée Claude Bernard Albi, France
  • CH Blois, France
  • Clinique Tivoli Ducos Bordeaux, France
  • Hôpital Duchenne Boulogne-sur-Mer, France
View all 37 locations
View Trial Details

Related conditions